Laura A Small

Title: Laura A. Small: Innovator in Gene Therapy

Introduction

Laura A. Small is a prominent inventor based in Gainesville, FL (US). She has made significant contributions to the field of gene therapy, particularly in the development of recombinant adeno-associated virus (rAAV) vectors. With a total of 2 patents, her work focuses on innovative methods to target and treat medullary thyroid carcinoma.

Latest Patents

Laura A. Small's latest patents include groundbreaking research on recombinant adeno-associated virus vectors designed to target medullary thyroid carcinoma. This patent provides nucleic acids, rAAV particles, and compositions, along with methods for transducing medullary thyroid carcinoma cells. The invention includes a truncated calcitonin promoter and rAAV particles with mutations that enhance transduction into cancer cells. Another significant patent involves methods for improving rAAV production in suspension-adapted cells by increasing the salt concentration in the media during the production process.

Career Highlights

Laura A. Small is affiliated with the University of Florida Research Foundation, Incorporated. Her work has been instrumental in advancing the understanding and treatment of medullary thyroid carcinoma through innovative gene therapy techniques.

Collaborations

Laura has collaborated with notable colleagues, including Nathalie Clement and Barry John Byrne, to further her research and development efforts in gene therapy.

Conclusion

Laura A. Small is a leading figure in the field of gene therapy, with her innovative patents paving the way for new treatments for medullary thyroid carcinoma. Her contributions continue to impact the medical community and advance cancer research.